AstraZeneca
Moderna’s trial diversity is all for show if Black and Brown Medicaid recipients can’t afford a vaccine
In the Covid-19 vaccine race, Moderna, Inc. made headlines last week for the representative diversity of its trial candidates.
A take on business from Times Square
Sponsored by NYC News Service and CUNY Newmark J-School
Section
In the Covid-19 vaccine race, Moderna, Inc. made headlines last week for the representative diversity of its trial candidates.
Moderna Inc.
About the Journal
The Times Square Investment Journal covers companies, markets and personal finance from a newsroom in the heart of Manhattan. The Journal is sponsored by the NYC News Service and the Craig Newmark Graduate School of Journalism at CUNY.
Send comments and story tips to the editor.
greg.david@journalism.cuny.edu